Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Gunn will provide medical and scientific leadership across metabolic liver disease research and specialized site operations.
February 12, 2026
By: Patrick Lavery
Content Marketing Editor
Iterative Health has hired Nadege Gunn, MD, as Chief Medical Officer (CMO), Hepatology and Obesity. Gunn currently practices at Texas-based Coryell Health, serving there as hepatology clinic director. She is the founder, and former president and CEO, of the hepatology-focused Impact Research Institute in Waco, Texas.
Gunn’s appointment to the Iterative Health team serves to provide strategic medical and scientific leadership in metabolic liver disease research. Gunn will also oversee specialized site operations to support Iterative Health’s expanding hepatology and obesity portfolio.
By strategically collaborating with biopharmaceutical sponsors and contract research organization (CRO) partners, Gunn will impact future plans for Iterative Health. These include creating a performance-driven network of research sites expanding access to multispecialty therapies, and accelerating novel therapies to market.
Iterative Health is also promoting Dana Feuchtbaum from Chief Product Officer to Chief Operating Officer. Feuchtbaum said that Gunn joining the team will benefit providers and sponsors alike.
“Gunn strengthens the clinical leadership and operational confidence behind every hepatology and obesity study we support,” Feuchtbaum said. “Her appointment accelerates our ability to support increasingly complex hepatology and obesity trials at scale.”
Gunn expressed excitement for Iterative Health’s focus on “extending cutting-edge clinical research into the communities that care for these patients.”
“Iterative Health has created an impressive foundation to advance hepatology and obesity research at scale,” Gunn said.
Impact Research Institute, which Gunn founded, is recognized as a leading U.S. hepatology research center. Gunn is also a committee member of Women in Hepatology: Initiatives, Sponsorship, and Empowerment within the Chronic Liver Disease Foundation.
Her academic resume includes teaching posts at Texas A&M, the University of Texas at Austin, and Baylor University.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !